Institut Pasteur de Bangui
About
IPB operates under an agreement with the Government of the Central African Republic and serves as an advisory establishment under the Ministry of Health and Population.
The Institut Pasteur de Bangui (IPB), founded in 1961, is a pillar of public health and biomedical research in the Central African Republic and a key member of the Pasteur Network. Initially focused on yellow fever control and arbovirus research, IPB has broadened its mission to address the region’s major health challenges.
As a key advisory body to the Ministry of Health and Population, IPB functions as a National Reference Laboratory for numerous pathogens, including hemorrhagic fever viruses, rabies, influenza, monkeypox and polio. Its core activities rest on four pillars: services to the population (clinical laboratory diagnostics, vaccination, and the anti‑rabies treatment center), research on endemic and emerging diseases, epidemiological surveillance, and training of a new generation of Central African scientists.
The institute deploys a multidisciplinary approach integrating virology, bacteriology, parasitology, epidemiology and entomology, positioning itself as a central actor of the “One Health” approach in Central Africa. In its 2024–2029 roadmap, IPB has initiated a strong reorganization to reinforce governance and public health impact.
